Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Microfluidics Market analysis
Part of: Microfluidics Market (Global)

The Australia Microfluidics Market was valued at $428.21 Million in 2025 and projected to reach to $580.98 Million by 2030, representing a compound annual growth rate of CAGR 6.3%. Australia's microfluidics market is poised for steady expansion, supported by increasing demand for rapid diagnostic solutions and point-of-care testing across healthcare facilities.

Australia Microfluidics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Microfluidics Market Trends and Insights

  • Australia is establishing itself as a key player in the Asia Pacific microfluidics sector, driven by advances in diagnostic technologies and point-of-care testing solutions.
  • The country's strong healthcare infrastructure and research capabilities position Australia favorably for microfluidic device adoption across clinical and laboratory settings. During the 2025–2030 forecast period, Australia's microfluidics market will benefit from increased investment in personalized medicine and lab-on-chip technologies.
  • Australia's growing demand for rapid diagnostic platforms and miniaturized analytical systems reflects broader healthcare modernization trends.
  • The 6.3% compound annual growth rate underscores Australia's commitment to innovation in healthcare delivery and precision diagnostics..

Key Market Statistics

  • CAGR (2025-2030) CAGR 6.3%
  • Market Size, 2025 ~USD 428.21 Million
  • Forecast, 2030 ~USD 580.98 Million
  • Country Australia

Australia Microfluidics Market Overview

Market Valuation :

Australia's microfluidics market is valued at $428.21 million in 2025, with a projected CAGR of 6.3% through 2030, reaching $580.98 million by forecast end.

Asia Pacific Leadership :

Australia is positioning itself as a key regional player in the Asia Pacific microfluidics sector, leveraging its advanced healthcare infrastructure and research capabilities.

Diagnostic Technology Advancement :

Growth is primarily driven by advances in diagnostic technologies and point-of-care testing solutions, addressing Australia's healthcare modernization priorities.

Research & Development Strength :

Australia's robust research institutions and healthcare sector investment create a favorable environment for microfluidics innovation and commercialization.

Australia Microfluidics Market Dynamics

  • The country's strong regulatory framework and investment in healthcare technology infrastructure provide a stable foundation for market growth.
  • With a 6.3% CAGR, the market reflects Australia's commitment to advancing diagnostic capabilities and improving patient outcomes through innovative microfluidic solutions. The Australian market benefits from collaborations between research institutions, healthcare providers, and technology companies.
  • Growing adoption of microfluidics in clinical laboratories and emerging applications in personalized medicine are expected to drive sustained growth.
  • As Australia strengthens its position in the Asia Pacific region, local manufacturers and international players are increasingly targeting the market with tailored solutions for Australian healthcare needs..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Key Takeaways

    • Australia's microfluidics market will grow from $428.21M (2025) to $580.98M (2030) at a 6.3% CAGR.
    • Australia is leveraging advanced diagnostic and point-of-care testing technologies to drive market expansion.
    • Australia's robust healthcare infrastructure supports widespread adoption of microfluidic devices across clinical applications.
    • Australia's investment in personalized medicine and lab-on-chip innovation positions the country as a regional growth leader.

    Microfluidics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment PCR SYSTEMS (Device)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.3% from 2025 to 2030
    Largest Segment MICROFLUIDICS-BASED DEVICES (Product)
    Market Size Base Year (Billions) ~USD 24.96 (2025)
    Revenue Forecast (Billions) ~USD 37.19 (2030)
    Segments Covered Product, Device, Type, Material, Application, End User

    Australia Microfluidics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Microfluidic
    • Microfluidic Components
    • Microfluidics-Based Devices

    By Device

    • Droplet & Particle Production System
    • Droplet & Particle Production Systems
    • Microfluidic Capillary Electrophoresis
    • Next-Generation Sequencing Systems
    • Ngs Systems
    • Other Devices
    • Pcr Systems

    By Type

    • Capillary Electrophoresis
    • Cell-Based Assays
    • Clinical Diagnostics
    • Drug Delivery
    • Flow & Pressure Controllers
    • Flow & Pressure Sensors
    • Genomic Analysis
    • Lab Analytics
    • Microdispensing
    • Microfluidic Chips
    • Microfluidic Valves
    • Microneedles
    • Micropumps
    • Microreactors
    • Other Microfluidic Components
    • Poct
    • Point-Of-Care Testing
    • Proteomic Analysis
    • Veterinary Diagnostics
    • Wearable

    By Material

    • Cyclic Olefin Copolymers
    • Glass
    • Other Materials
    • Polydimethylsiloxane
    • Polymethyl Methacrylate
    • Silicon

    By Application

    • Ivd
    • Pharmaceutical & Life Science Research
    • Therapeutics

    By End User

    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Australia-specific market data to assess market entry viability, competitive positioning, and demand forecasts for microfluidic diagnostic devices in the region.
    • Healthcare Providers & Hospitals : Australian hospitals and diagnostic centers require market insights to evaluate microfluidics technology adoption, understand emerging solutions, and plan procurement strategies.
    • Research & Development Institutions : Universities and research organizations in Australia need market intelligence to align innovation efforts with commercial opportunities and identify funding and partnership prospects.
    • Investment & Venture Capital Firms : Investors targeting the Australian healthcare technology sector need detailed market analysis to identify promising microfluidics startups and growth opportunities for portfolio allocation.
    • Government & Policy Makers : Australian health authorities and policy makers require market data to inform healthcare technology strategies, funding decisions, and regulatory frameworks for microfluidics innovation.

    Key Companies in the Australia Microfluidics Market

    CompanyHQOwnershipStrongest segments
    BECKMAN COULTERUnited StatesPrivate CompanyChips,Sensors,Valves,
    RAINDANCE TECHNOLOGIESUnited StatesPrivate CompanyChip,Sensor,Valve,
    HALMA PLCUnited KingdomPublic CompanySensor,Valve,Pump,
    X-FABGermanyPublic CompanyChip,Sensor,Valve,
    TECHNICOLOR SAFrancePublic CompanyChip,Sensor,Valve,
    MAXCYTE, INCUnited StatesPublic CompanyMicrofluidic Chips and Cell-Handling Cartridges (linked to ExPERT PAs),Electroporation Instruments (ExPERT ATx, STx, GTx, VLx),Buffers, Software Protocols, and Accessories,
    DANAHER CORPORATIONUnited StatesPublic CompanyMicrofluidic Chips & Cartridges,Microfluidic Sensors,Microfluidic Valves & Pumps,
    ILLUMINA, INC.United StatesPublic CompanyMicrofluidic Chips (including flow cells and integrated cartridges),Microfluidic Sensors,Microfluidic Valves and Pumps,
    BIOMÉRIEUXFrancePublic CompanyChip,Sensor,Valve,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    ABBOTT LABORATORIESUnited StatesPublic CompanyChip,Sensor,Valve,
    PARKER HANNIFIN CORPUnited StatesPublic CompanyValves,Pumps,Sensors,
    SMC CORPORATIONUnited StatesPublic CompanyAI and HPC servers for life-science workloads,Rack-scale solutions for hospital and diagnostic datacenters,Embedded and edge (5G/IoT/Edge) systems,
    IDEX CORPORATIONUnited StatesPublic CompanyPumps,Valves,Sensors,
    FORTIVEUnited StatesPublic CompanyChip-adjacent instrumentation and test,Sensor and pump calibration tools,Sterilization and instrument tracking (microfluidic-enabled devices),
    REVVITY, INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyChip,Sensor,Valve,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyChips,Sensors,Valves,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyChip,Sensor,Valve,
    STANDARD BIOTOOLSUnited StatesPublic CompanyMicrofluidic Chips & Consumables,Microfluidic Instruments & Systems,Services, Software & Licensing,

    BECKMAN COULTER

    Beckman Coulter is a United States-based diagnostics and life sciences company founded in 1935 with 11,900 employees. As a private company, it provides laboratory instruments and reagents for clinical and research applications.

    RAINDANCE TECHNOLOGIES

    Raindance Technologies is a United States-based private company founded in 2004 with 104 employees. It develops digital PCR and microfluidic technologies for genomic analysis and molecular diagnostics.

    HALMA PLC

    Halma PLC is a United Kingdom-based public company founded in 1894 with 9,000 employees. It operates as a diversified group providing safety, environmental, and life sciences solutions across multiple markets.

    X-FAB

    X-FAB is a Germany-based public company founded in 1992 with 4,300 employees. It is a specialty semiconductor foundry providing analog and mixed-signal semiconductor manufacturing services.

    TECHNICOLOR SA

    Technicolor SA is a France-based public company founded in 1985 with 1,552 employees. It provides media and entertainment technology services including post-production, digital cinema, and content delivery solutions.

    MAXCYTE, INC

    MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees. It develops electroporation technology platforms for cell engineering and therapeutic applications.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. It operates as a diversified conglomerate providing products and services in life sciences, diagnostics, environmental, and applied solutions.

    ILLUMINA, INC.

    Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. It is a leading provider of DNA sequencing and array-based solutions for genomic analysis.

    BIOMÉRIEUX

    bioMérieux is a France-based public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a global leader in serving science, providing laboratory equipment, reagents, software, and services for research and diagnostics.

    ABBOTT LABORATORIES

    Abbott Laboratories is a United States-based public company founded in 1888 with 115,000 employees. It is a diversified healthcare company providing pharmaceuticals, diagnostics, nutritional products, and medical devices.

    PARKER HANNIFIN CORP

    Parker Hannifin Corp is a United States-based public company founded in 1917 with 57,950 employees. It manufactures motion and control technologies including hydraulic, pneumatic, and electromechanical systems.

    SMC CORPORATION

    SMC Corporation is a United States-based public company founded in 1993 with 6,238 employees. It manufactures pneumatic and electric automation components and systems for industrial applications.

    IDEX CORPORATION

    IDEX Corporation is a United States-based public company founded in 1987 with 8,700 employees. It provides fluid and metering technologies, dispensing equipment, and safety systems for various industrial and life sciences applications.

    FORTIVE

    Fortive is a United States-based public company founded in 2015 with 10,000 employees. It operates as a diversified industrial technology conglomerate providing software, services, and equipment for manufacturing and infrastructure.

    REVVITY, INC.

    Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees. It provides analytical instruments, software, and services for life sciences research, diagnostics, and environmental testing.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. It provides analytical instruments, software, and services for life sciences, diagnostics, and chemical analysis.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. It manufactures and distributes life science research products and clinical diagnostics solutions.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

    STANDARD BIOTOOLS

    Standard Biotools is a United States-based public company founded in 1999 with 387 employees. It develops microfluidic and single-cell analysis technologies for life sciences research and diagnostics.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation figures for Australia's microfluidics market ($428.21M in 2025) with detailed CAGR projections through 2030, enabling accurate financial forecasting and investment planning.
    • Regional Competitive Intelligence : Understand Australia's positioning within the Asia Pacific microfluidics landscape, identifying competitive advantages and market opportunities specific to the Australian healthcare sector.
    • Technology & Application Insights : Gain detailed analysis of diagnostic technologies and point-of-care testing solutions driving growth in Australia, with insights into adoption rates and clinical implementation trends.
    • Strategic Market Entry Planning : Leverage Australia-specific market data to develop targeted go-to-market strategies, identify key stakeholders, and assess regulatory requirements for microfluidics products and services.
    • Investment & Partnership Opportunities : Identify high-potential segments and collaboration opportunities with Australian research institutions, healthcare providers, and technology companies in the microfluidics ecosystem.

    Frequently asked questions

    What is the current size of Australia's microfluidics market?

    Australia's microfluidics market is valued at $428.21 million in 2025.

    What is the projected market size for Australia's microfluidics sector by 2030?

    Australia's microfluidics market is forecast to reach $580.98 million by 2030.

    What is the growth rate of Australia's microfluidics market?

    Australia's microfluidics market is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2030.

    What are the primary drivers of growth in Australia's microfluidics market?

    Australia's microfluidics market growth is driven by advances in diagnostic technologies, point-of-care testing, personalized medicine, and lab-on-chip innovations.

    How does Australia's microfluidics market compare to the global market?

    Australia's 6.3% CAGR is slightly below the global average of 8.3%, reflecting a more measured but stable growth trajectory within the Asia Pacific region.

    RESEARCH METHODOLOGY

    Four main studies were done to estimate the market size of microfluidics. Secondary research was carried out to obtain data associated with the market, peer markets, and parent markets. After that, data was obtained from 3-5 secondary sources; the findings, assumptions, and sizing were confirmed through primary sources. Top-down and bottom-up approaches were utilized to gain insights on complete market size. After that, market breakdown and data triangulation were used to determine the market size of segments and subsegments.

    Secondary Research

    Directories, databases like D&B Hoovers, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings and investor presentations are few of the important sources used in the secondary research. This helps in gaining fundamental details about prominent companies and market segmentation as per the industry trends at numerous levels and technological viewpoints related with the Microfluidics market.

    Primary Research

    The primary research compromised performing interviews from both the supply and demand sides to obtain quantitative and qualitative data. CEOs, area sales managers, territory sales managers, regional sales managers and other important officials from top businesses are the primary sources from the supply side. Physicians, researchers, department heads, and staff members from diagnostic centers, hospitals and research institutes were the primary sources from the demand side. The target of this study was to verify the conclusions and assumptions from secondary research by interacting with stakeholders directly.

    A breakdown of the primary respondents is provided below:

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The revenue share analysis of the major key players for the size of the Microfluidics market is given in this study. Primary and secondary research are used to find prominent players in the Microfluidics and to gain insights of their financials and market share. The primary research approach comprises extremely in-depth interviews with CEOs, directors, and senior marketing executives, while the secondary research procedure mostly relied on the annual and financial reports of major players. Segment-based technique was used to determine the global market value. The revenue details of significant solution and service suppliers was then applied to source these segmented revenues.

    The steps in the procedure  are

    • List the key global companies that are associated with the Microfluidics industry. Note the annual revenues of the players in the Microfluidics industry or the product category/business division.
    • As of 2024, it represents an important portion of the market based on revenue mapping of the key competitors. Extrapolation to the global value for the Microfluidics market.

    Data Triangulation

    The Microfluidics market was categorized into various segments and subsegments with the help of the above procedure. Then, data triangulation and the market segmentation process are carried out to ensure the accuracy of the data for each segment. Factors and trends from demand and supply sides were studied . Top-down and bottom-up approaches provide the outcome from the analysis of the Microfluidics market.

    Market Definition

    The microfluidics market includes products and technologies that are developed to analyse and regulate fluid volume through microfluidic devices and components. The market covers both the microfluidics components that are important for the working of microfluidics-based devices, such as lab-on-a-chip systems and diagnostic assays, as well as the devices. Microneedles, micropumps, flow and pressure sensors, controllers, and microfluidic valves are some of the important components of microfluidics-based device.Polymers, silicon, and glass are most often used in the development of these components. The market provides innovative technologies for effective and precise fluid management and analysis, which have beneficial applications in research and diagnostics.

    Stakeholders

    • Microfluidic product manufacturers
    • Microfluidic product distributors
    • Pharmaceutical companies
    • IVD manufacturers
    • In vitro diagnostic test (IVD) distributors
    • Research institutes
    • Contract manufacturing organizations (CMOs)
    • Contract research organizations (CROs)
    • Healthcare institutions (hospitals, medical schools, and outpatient clinics)
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the microfluidics market by product, application, end-user, and region
    • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
    • To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, and patent analysis
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the microfluidics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To profile the prominent players in this market and comprehensively analyze their market shares and core competencies
    • To strategically analyze the microfluidics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments such as acquisitions, product launches, product approvals, partnerships, and expansions in the microfluidics market

     

    Get the Full Microfluidics Market Report

    Full forecast, segment splits, and company analysis for all Microfluidics Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status